XML 73 R58.htm IDEA: XBRL DOCUMENT v3.20.4
SHAREHOLDERS' EQUITY (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
$ / shares
shares
Jan. 31, 2019
$ / shares
shares
Nov. 30, 2018
USD ($)
$ / shares
shares
Apr. 30, 2015
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2020
₪ / shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
₪ / shares
shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Ordinary shares, shares authorized | shares                 100,000,000 100,000,000 100,000,000
Ordinary shares, par value | (per share)               ₪ 0.03   ₪ 0.03 $ 0.03
Number of shares sold, value         $ 23,537 $ 1,500 $ 12,252        
Stock-based compensation expense         1,436 1,148 898        
Intrinsic value of options exercised         $ 4,596 1,192 $ 173        
2015 Share Option Plan [Member]                      
Number of stock options shares grant to purchase | shares       1,500,000              
Option expire term             10 years        
Additional option expiry term             10 years        
Stock option exercisable description       25% of the option granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years.              
Number of shares available for grant | shares                 164,592    
Ordinary Shares Underwritten Public Offering [Member]                      
Number of shares sold, shares | shares 4,819,052                    
Proceeds from issue of underwritten public offering $ 25,300                    
Shares sale price per share | $ / shares $ 5.25                    
Offering cost $ 1,800                    
DBSI [Member]                      
Number of shares sold, shares | shares   545,454                  
Shares sale price per share | $ / shares   $ 2.75                  
Israeli Institutional Investors [Member]                      
Number of shares sold, shares | shares     4,545,454                
Shares sale price per share | $ / shares     $ 2.75                
Number of shares sold, value     $ 12,500                
Offering cost     $ 248                
Employees and Directors [Member]                      
Unamortized compensation expenses period         4 years            
Unamortized compensation expenses                 $ 3,629    
Weighted average grant date fair value of options granted         $ 2,340 $ 1,060 $ 2,179        
NIS [Member]                      
Value of shares authorized                     $ 1,875
NIS [Member] | Maximum [Member]                      
Value of shares authorized                     $ 3,000